Unlock instant, AI-driven research and patent intelligence for your innovation.

Circular RNA marker for detecting Crohn's disease and application

A Crohn's disease and marker technology, applied in the field of molecular biomedicine, can solve the problems of low sensitivity and specificity

Active Publication Date: 2020-10-02
SUZHOU MUNICIPAL HOSPITAL
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The sensitivity and specificity of existing blood molecular biomarkers for CD are not high; there are no mature kits that apply circRNA molecules in CD diagnosis and curative effect judgment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Circular RNA marker for detecting Crohn's disease and application
  • Circular RNA marker for detecting Crohn's disease and application
  • Circular RNA marker for detecting Crohn's disease and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Example 1 CD Peripheral Blood Mononuclear Cell Separation

[0031] Peripheral blood was collected from patients with Crohn's disease and healthy controls using EDTA-K2 anticoagulant tubes, and 6 mL of blood was collected from each case. At the time of sample collection, all participants had not used immunosuppressants and oral antibiotics within 3 months, and had no other chronic diseases. All patients with Crohn's disease were diagnosed by endoscopy, and ulcerative colitis, Behcet's disease, and irritable bowel syndrome were excluded. The healthy control subjects had no gastrointestinal diseases and other chronic diseases in the physical examination center of the hospital, and all indicators were normal before sampling. After the sample is collected, it is quickly sent to the central laboratory for the isolation of peripheral blood mononuclear cells, and the isolation is completed within 2 hours. Peripheral blood mononuclear cells were separated by the Ficoll method,...

Embodiment 2

[0044] Example 2 Total RNA extraction

[0045] 2.1 Collect cells by centrifugation, add 1 ml of TRIzol to every 5-10×106 cells, and pipette repeatedly. Do not wash cells before adding TRIzol to avoid mRNA degradation.

[0046] 2.2 Put the sample at room temperature (15-30°C) for 5 minutes to completely separate the nucleic acid-protein complexes.

[0047] 2.3 Add 0.2 ml of chloroform for every 1 ml of TRIzol used, shake vigorously for 15 seconds, and place at room temperature for 3 minutes.

[0048] 2.4 Centrifuge at 10000×g at 2-8°C for 15 minutes. The sample is divided into three layers: the bottom layer is the yellow organic phase, the upper layer is the colorless aqueous phase and an intermediate layer. The RNA is mainly in the aqueous phase, which is about 60% of the volume of the TRIzol reagent used.

[0049] 2.5 Transfer the aqueous phase to a new tube. If you want to separate DNA and protein, you can keep the organic phase. See below for further operations. RNA in...

Embodiment 3

[0053] Example 3 Reverse transcription and quantitative detection of hsa_circRNA_009084 qPCR

[0054] with PrimeScript TM The Master Mix (TaKaRa, Shiga, Japan) kit reverse transcribed RNA into cDNA. With β-actin as internal reference, TB Green TM Premix Ex Taq TM II (TliRNaseH Plus; TaKaRa, Shiga, Japan) kit dye method qPCR was used to detect the relative expression levels of target circRNA molecules in Crohn's disease patient group and control group samples.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a circular RNA marker for detecting Crohn's disease and an application. In 155 upregulated circRNA molecules of a CD patient subjected to chip screening, the has_circRNA _ 009084 has excellent performance in evaluation of diagnosis sensitivity and specificity. The hsa _ circRNA _ 009084 for CD diagnosis provided by the invention has no related literature reports and patentapplications at home and abroad. According to the technology, only an RT-PCR method is needed for detecting hsa _ circRNA _ 009084 molecules in blood, the operation is simple and easy, and the clinical application and popularization feasibility is high; and the hsa _ circRNA _ 009084 can be applied to rapid judgment of CD diagnosis and curative effect. The invention provides the circular RNA marker for detecting Crohn's disease. The circular RNA marker is hsa _ circRNA _ 009084. The invention provides the application of the circular RNA marker for detecting the Crohn's disease. The circular RNA marker is hsa _ circRNA _ 009084 which is used as a marker in a Crohn's disease detection method.

Description

technical field [0001] The invention belongs to the field of molecular biomedicine, in particular to Crohn's disease. Background technique [0002] In recent years, the incidence of inflammatory bowel disease (Inflammatory bowel disease, IBD), including Crohn's disease (Crohn's disease, CD) and ulcerative colitis (ulcerative colitis, UC) is increasing in developing countries. [0003] Circular RNAs (circular RNAs, circRNAs) are back-spliced ​​from messenger RNA precursors (pre-mRNAs), and may contain intron sequences, exon sequences, or both intron and exon sequences. Most circRNAs are non-coding RNAs (non-coding RNAs, ncRNAs) that can perform regulatory functions, and can regulate gene expression at the transcriptional or post-transcriptional level by adsorbing microRNA or binding to other molecules. circRNA is not affected by exonuclease due to its closed circular structure, has a long half-life, can stably exist in cells, and has certain tissue specificity, timing specif...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6883C12N15/11
CPCC12Q1/6883C12Q2600/178C12Q2600/106
Inventor 尹娟庞智叶玉兰胡彤张丽平李平
Owner SUZHOU MUNICIPAL HOSPITAL